Brain tumors are abnormal cell growths in the brain that may be cancerous or benign, disrupting normal function and posing serious health risks. Standard detection often relies on expert manual classification, which is not always available in low-resource settings. A new arXiv preprint introduces BrainAid, a framework designed to address this gap using lightweight convolutional neural networks (CNNs) paired with explainable AI.

The approach prioritizes efficiency, making it suitable for environments with limited computational power or connectivity. By incorporating explainable AI, the model aims to provide not just predictions but also interpretable reasoning, which is critical for clinical trust and adoption. The authors position BrainAid as an alternative to heavier deep learning systems that may be impractical in such contexts.

The source is a preprint, so details on architecture, dataset, and quantitative results are not yet available in the abstract. The work highlights a growing trend toward deploying AI in constrained settings while keeping transparency a core feature.